News | July 15, 2025
WHO, ITU, and WIPO release new report on AI use in traditional medicine
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
The agency concluded that for people of all ages, IXCHI should be administered when there is a significant risk of chikungunya infection
Capricor’s BLA for Deramiocel received Priority Review in March 2025
LEQSELVI now available for prescription in U.S. nationwide, offering a new option for eligible patients
In collaboration with the Gates Foundation, Merck advances MK-8527 pre-exposure prophylaxis (PrEP) clinical trials globally
Ukhade brings deep expertise in large-scale infrastructure planning, cross-functional leadership, and project innovation.
Spikevax is now approved for all individuals aged 6 months through 64 years at increased risk for COVID-19 disease
Apotex will also pay US$ 2.5 million upon receipt of final USFDA approval of the ANDA that is the subject of the Collaboration Agreement for Paclitaxel Protein-Bound Particles for Injectable Suspension
This collaboration marks a significant milestone for Abluva as the company aims to deliver value and innovative solutions in agentic AI security
Apollo AyurVAID’s product line features clinically proven formulations certified safe by NABL-accredited laboratories for heavy metals, aflatoxins, microbial content
Subscribe To Our Newsletter & Stay Updated
